Late breaking abstracts #ASTRO22 - Chad Tang, MD EXTEND trial; oligometastatic #prostatecancer . Intermittent ADT + SABR versus ADR alone extends PFS, but importantly time men enjoy off ADT in the long term (eugonadal PFS). Important patient centric endpoint! 👏🏽⭐️ OncoAlert #pcsm

It's time we ban assault weapons in this country.

Our very own Dr. Roy Decker was awarded the 2022 Mark Reitsma Courage Award at this year's #CTFRide in recognition of riders battling cancer. As a former program director, he is a pillar of our residency and an inspiration to us all.

Drug pricing (& price discrimination) extravaganza in JAMA Internal Medicine this week, starting off with study of human vs pet prices. Why do human formulations of meds cost 10-fold >> pet version of same drugs? bit.ly/3qCVNVW Kudos Waqas Haque
& team. (1/3)

Talented musicians, but even more compassionate radiation oncologists. Come learn how music influenced our residents @MatthewGarrett and Connor Kinslow, MD from becoming great doctors. healio.com/news/hematolog… Columbia Cancer NewYork-Presbyterian

This 100%

'..modern #radiationtherapy is..cost effective & responsibly delivered...time to let go of the tired notion that #radonc is an overly costly therapy.' James Yu

#ROmodel #ROAPM #AVBCC2022
Value-Based Cancer Care

redjournal.org/article/S0360-…

Finally here:
1/ long term outcomes of the 2 RCT on #oligometastatic #prostatecancer (STOMP and ORIOLE).
2/Analysis of the impact of somatic mutations in 'high-risk' genes on outcome bit.ly/3CvR92V.

While the VA sorts out how to spend close to $500M a week to meet the vision of the #PACTAct , I’ll share a personal story from the perspective of a VA lung cancer specialist who has met soldiers exposed to burn pits. 1/ 🧵

'Now out in JNCI - this global multicenter study developed risk prediction models for early-onset #colorectalcancer that incorporates 16 lifestyle and environmental factors and a polygenic risk score of 141 variants. #crcsm #ayacsm
Read more: bit.ly/3mw4wa6'

Wonderful group that came together to say exactly why #Dobbs is a huge problem for cancer patients and oncologists, as well as all of us Reshma Jagsi Eric Ford, PhD Rachel Blitzblau Gabrielle W Peters, MD Christina Chapman, M.D., M.S. + many more!
sciencedirect.com/science/articl…

A tweetorial (1/x):
Today, we announce our latest story in Science Magazine, on an entirely new approach to exploit DDR defects, from the Herzon Lab & Bindra Labs. We cherish every paper we publish, but this one resonates for many reasons...Yale Cancer Center
science.org/doi/10.1126/sc…

This was very fun- I got to learn from my friends and colleagues Jona Hattangadi-Gluth, MD Vinai Gondi Eric Chang of USC_Radonc and Veronica Chiang of Yale School of Medicine about this very important topic! #brainmets #radonc

Patients with cancer who have Medicaid insurance still face challenges in accessing high-quality cancer care in the US.

We found that just 67.7% of CoC-accredited facilities offered *high access* across common cancer types to patients with Medicaid
jamanetwork.com/journals/jaman…

Love this cover!

Very excited to part of the creation of the first National Comprehensive Cancer Network (NCCN) guidelines for Pediatric Brain Cancer... learned a lot from my colleagues across multiple oncology disciplines in this realm 🙌

@yalecancer
Yale Radiation Oncology Residency

bit.ly/3O2HQtm